Preferences help
enabled [disable] Abstract
Number of results
2014 | 9 | 3 | 9-23
Article title

Rola wybranych polimorfizmów genów kodujących cytokiny IL-1ß, IL1ra, IL-6 i TNFα w patogenezie porodu przedwczesnego

Title variants
The role of chosen polymorphism of gens coding cytokines IL-1ß, IL1ra, IL-6 and TNF α in the pathogenesis of the preterm delivery
Languages of publication
Inflammation is a known risk factor for preterm delivery (PTD). Infection in pregnant woman is responsible for up to 40% cases of PTD. Intrauterine invasion of germs, chorioamonitis, sepsis, urinary tract infections, malaria, pneumonia are diseases with proven connection with PTD. Hyper- or hypostimulation of immune system in pregnant woman may lead to inappropriate reaction for stimuli (e.g. infection), resulting in ripening of cervix, preterm premature rupture of membranes (PPROM), uterus contractility and PTD. Interleukines are proteins, which are produced as a response for inflammation. They regulate all processes that help fight infection and provide healing. As other proteins the production of interleukines is regulated by DNA. Changes in DNA like polymorphisms are responsible for e.g. inadequate production of interleukines or production of inactive praticles of protein. Single nucleotide polymorphism (SNP) is a change in one particular place in DNA chain (called locus) that is defined as a replacement in one of nucleic alkali to another. The interleukine-1 beta (IL-1ß), interleukine-6 (IL-6) and tumor necrosis factor alfa (TNFα) are proinflammatory cytokines. Particular polimorphisms in genes that codes these proteins (i.e. IL1B+3953, IL6-174 and TNFA-308 respectively) induce the inadequate production of cytokines resulting in PPROM and PTD. Interleukine-1 receptor antagonist (IL1ra) is antyinflammatory cytokine that bounds competitively with receptor for IL-1ß but gives any biological effect typical for proinflammatory IL-1b. Polymorphism in intron 2 of interleukine-1 receptor antagonist gene (IL1RN) reduces production of IL1ra, which affects balance between IL1ra and IL-1ß and leads to inadequate inflammatory response and PTD.
Physical description
  • 1. Blencowe H, Cousens S, Oestergaard MZ et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 2012; 379 (9832): 2162-72.
  • 2. Brêborowicz GH, Paszkowski T i wsp. Poród przedwczesny 2006; ISBN 87-7314-053-0.
  • 3. Romero R, Espinoza J, Kusanovic JP et al. The preterm parturition syndrome. RCOG 2006 BJOG An International Journal of Obstetrics and Gynaecology 2006; 113 (3): 17-42.
  • 4. Romero R, Espinoza J, Chaiworapongsa T et al. Infection and prematurity and the role of preventive strategies. Semin Neonatol 2002; 7: 259-74.
  • 5. Romero R, Espinoza J, Goncalves LF et al. Inflammation in preterm and term labour and delivery. Seminars in Fetal & Neonatal Medicine 2006; 11: 317-26.
  • 6. Blank V, Hitsch E, Challis JRG et al. Cytokine signaling, inflammation, innate immunity and preterm labour- a workshop report. Placenta 29, Supplement A, Trophoblast Research 2008; 22: 102-4.
  • 7. Holst D, Garnier Y. Preterm birth and inflammation The role of genetic polymorphisms. European Journal of Obstetrics & Gynecology an Reproductive Biology 2008; 141:3-9.
  • 8. Bręborowicz GH, Paszkowski T. Położnictwo t.2. 2012:19-40; ISBN 978-83-200-4271-9,
  • 9. Migone A, Emanuel I, Mueller B et al. Gestational duration and birthweight in white, black and mixed-race babies. Paediatr Perinat Epidemiol 1991; 5: 378-91.
  • 10. Magnus P. Causes of variation in birthweight: a study of offspring of twins. Clin Genet 1984; 25:15-24.
  • 11. Magnus P. Further evidence of significant effect of fetal genes on variation in birth weight. Clin Genet 1984; 26:289-96.
  • 12. Li DK. Changing paternity and the risk of preterm delivery in the subsequent pregnancy. Epidemiology 1999; 10:148-52.
  • 13. Basso O, Olsen J, Christiansen K. Low birthweight and prematurity in relation to paternal factors: a study of reccurence. Int J Epidemiol1999;28:695-700.
  • 14. Adams K, Eschenbach D. The genetis contribution towards preterm delivery. Seminars in fetal & neonatal medicine 2004; 9: 445-52.
  • 15. Esplin S, Varner M. Genetic factor in preterm birththe future. BJOG 2005; 112 (sup1): 97-102.
  • 16. Rudnik-Schoneborn S, Nicholson GA, Mordan G et al. Different patterns of obstetric complication in myotonic dystrophy in relation to the disease status of the fetus. Am J Med Genet1998;80:314-21.
  • 17. Orsi N, Gopichandran N, Simpson N. Genetics of preterm labor. Best Practice & Research Clinical Obstetrics and Gynaecology 2007; 21(5): 757-72.
  • 18. Engel S, Erichsen H, Savitz D et al. Risk of spontaneus preterm birth is associated with common proinflammatory cytokine polymorphisms. Epidemiology 2005; 16(4): 469-77.
  • 19. Mira J, Cariou A, Grall F et al. Association of TNF2, a TNF A promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA1999;282:561-8.
  • 20. Wilson AG, Symons JA, McDowell TL et al. Effects of polymorphism in the human tumor necrosis factor A promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94: 3195-9.
  • 21. Fishman D, Faulds G, Jeffery R et al. The effect of novel polymorphisms in the IL-6 gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest1998;102;1369-76.
  • 22. Gentile DA, Doyle WJ, Zeevi A et al. Cytokine gene polymorphisms moderate illness severity in infants with respiratory syntytial virus infection. Hum Immunol2003;64:338-44.
  • 23. Engel S, Olshan A, Savitz D et al. Risk of small-forgestational age is associated with common anti-inflammatory cytokne polymorphisms. Epidemiology2005; 16(4):478-86.
  • 24. Strauss JF. Unravelling the genetics of complex disor- der of reproduction. Reprod Med: A Millenium Review1999:284-7.
  • 25. Kornman KS, Crane A, Wang HY et al. The interleukin-1 genotype as severity factor in adult peridontal disease. J Clin Peridontol1997;24:72-7.
  • 26. Genc M, Gerber S, Nesin M et al. Polimorphism in the interleukin-1 gene complex an spontaneous preterm de- livey. Am J Obstet Gynecol2002;187(1):157-63.
  • 27. Hillier SL, Witkin SS, Krohn MA et al. The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histological chorioamnionitis, and chorioamnion infection. Obstet Gynecol1993; 81:941-8.
  • 28. Goldenberg RL, Haut JC, Andrews WW. Intrauterine infection and preterm delivery. N Engl J Med 2000; 342:1500-7.
  • 29. Watts DH, Krohn MA, Hillier SL et al. The association of occult amniotic fluid infection with gestational age and neonatal outcome among women in preterm labor. Obstet Gynecol1992;79:351-7.
  • 30. Andrews WW, Hauth JC, Goldenberg RL et al. Amniotic fluid interleukin-6: correlation with upper genital tract microbial colonisation and gestational age in wo- men delivered after spontaneous labor versus indicated delivery. Am J Obstet Gynecol1995;173:606-11.
  • 31. Romero R, Mazor M, Sepulveda W et al. Tumor necrosis factor in preterm and term labor. Am J Obstet Gynecol1992;166:1576-82.
  • 32. Romero R, Gomez R, Ghezzi F et al. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet Gynecol1998;179:186-93.
  • 33. Yoon BH, Romero R, Park JS et al. Microbial invasion of the amniotic cavity with Ureaplasma urealyticum is associated with a robust host response in fetal, amniotic, and maternal compartments. Am J Obstet Gynecol1998;179:1254-60.
  • 34. Wegmann TG, Lin H, Guilbert L et al. Bidirectional cytokines interactions in the maternal-fetal relationship is successful pregnancy a th2 phenomenon. Immunol To- day 1993;14:353-6.
  • 35. Marzi M, Vigano A, Trabattoni D et al. Characterisation of type 1 and type 2 cytokine production profile in physiologic and pathologic human prenancy. Clin Exp Immunol1996;106:127-33.
  • 36. Fortunado SJ, Menon R, Lombardo SJ. Interleukin- 10 and transforming growth factor-beta inhibit amnio- chorion tumor necrosis factor-alpha production by con- trasting mechanisms of action: therapeutic implications in prematurity. Am J Obstet Gynecol1997;177(4):803- 9.
  • 37. Edwards R, Ferguson R, Duff P. The interleukin-1B +3953 single nucleotide polymorphism: Cervical protein concentration and preterm delivery risk. Am J Reprod Immunol2006;55:259-64.
  • 38. Webb AC, Collins KL, Auron PE et al. Interleukin-1 gene (IL1) assigned to long arm of human chromosome 2. Lymphokine Res1986;5:77-85.
  • 39. Choi Y, Kwak-Kim J.Cytokine gene polymorpfisms in recurrent spontaneous abortions: A comprehensive re- view. American Journal of Reproductive Immunology2008;60:91-110.
  • 40. Pociot F, Molving J, Wogensen L et al. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest1992;22:396-402.
  • 41. Hernandez-Guerrero C, Mononz-Bordonaba F, Ji- menz-Zamudio L et al. In-vitro secretion of proinflammatory cytokines by human amniochorion carrying hyper-responsive gene polymorphisms of tumor necro- sis factor-A and interleukin-1B. Mol Hum Reprod2003;9:625-9.
  • 42. Hollegaard MV, Bidwell JL. Cytokine gene polymorphism in human disease: on-line database, Supplement 3. Genes Immun2006;7:169-76.
  • 43. Moore S, Ide M, Randhawa M et al. An investigation into the association among preterm birth, cytokine gene polymorphisms and peridontal disease. BJOG2004; 111:125-32.
  • 44. Murtha A, Nieves A, Hauser E et al. Association of maternal IL-1 receptor antagonist intron 2 gene polymor- phism and preterm birth. Am J Obstet Gynecol2006; 195:1249-53.
  • 45. Hurme M, Santtila S. IL-1 receptor antagonist (IL-1ra) plasma levels are co-ordinately regulated by both IL-1ra and IL-1beta genes. Eur J Immunol1998;28:2598-602.
  • 46. Genc MR, Onderdonk A, Vardhana S et al. Polymor- phism in intron 2 of the interleukin-1 receptor antago- nist gene, local midtimester cytokine response to vagi- nal flora, and subsequent preterm birth. Am J Obstet Gynecol2004;191:1324-30.
  • 47. Perni S, Vardhana S, Tuttle S et al. Fetal interleukin- 1 receptor anatgonist gene polymorphism, intra-amnio- tic interleukin-1B levels, and history of spontaneous abortion. Am J Obstet Gynecol2004;191:1318-23.
  • 48. Genc MR, Witkin SS, Delaney ML et al. A disproportionate increase in IL-1B over IL-1ra in the cervicova- ginal secretions of pregnant women with altered vagi- nal microflora correlates with preterm birth. Am J ob- stet Gynecol2004;190:1191-7.
  • 49. Danis VA, Millington M, Hyland VJ et al. Cytokine production by normal human monocytes: Inter-subject variation and relationship to an IL-1 receptor antagonist (IL1-ra) gene polymorphism. Clin Exp Immunol1995: 99:303-10.
  • 50. Chaves JHB, Babayan A, de Melo Bezerra C et al. Maternal and Neonatal Interleukin Receptor Antagonist Genotype and Pregnancy Outcome in a Population with a High Rate of Pre-term Birth. American Journal of Reproductive Immunology2008;60:312–17.
  • 51. Hao K, Xiaobin W, Niu T et al. A candidate gene association study on preterm delivery: application of highthroughput genotypin technologyand advanced statisti- cal methods. Human Molecular Genetics2004; 13(7):683-91.
  • 52. Bessler H, Osovsky M, Sirota L. Association between IL-1ra gene polymorphism and premature delivery. Biol Neonate2004;85:179-83.
  • 53. Kalish R, Vardhana S, Gupta M et al. Interleukin-1 receptor antagonist gene polymorphism and multifetal pegnancy outcome. AJOG2003:911-4.
  • 54. Jamie W, Edwards R, Ferguson R et al. The interleu- kin-6 -174 single nucleotide polymorphism: Cervical protein production and the risk of preterm delivery. Am J Obstet Gynecol2005;192:1023-7.
  • 55. Velez D, Fortunato S, Williams S et al. Interleukin-6 (IL-6) andreceptor (IL-6R) gene haplotypes asociate with amniotic fluid protein concentrations in preterm birth. Human Molecular Genetics2008;17(11):1619-30.
  • 56. Stonek F, Metzenbauer M, Hafner E et al. Interleu- kin 6 -174G/C promoter polymorphism and pregnancy complications: result of a prospective cohort study in 1626 pregnant women. American Journal of Reprouc- tive Immunology2008;59:347-51.
  • 57. Simhan H, Krohn M, Roberts J et al. Interleukin-6 promoter -174 polymorphism and spontaneus preterm birth. Am J Obstet Gynecol2003:915-8.
  • 58. Hartel Ch, Finas D, Ahrens P et al. Polymorpfisms of genes involved in innate immunity: associaton with preterm delivery. Molecular Human Reproduction2004;10(12):911-5.
  • 59. Kilpinen S, Hulkkonen J, Wang XY et al. The promoter polymorphism of the interleukin -6 gene regulates iln- terleukin -6 production in neonates but not in adults. Eur Cytokine Netw2001;12:62-8.
  • 60. Muller-Steinhardt M, Hartel C, Muller B et al. The interleukin-6-174 promotor polymorphism is associated with long-term kidney allograft survival. Kidney Int2002;62:1824-7.
  • 61. Flex A, Gaetani E, Pola R et al. The -174 G/C poly- morphism of the interleukin-6 gene promotor is associa- ted with peripheral artery occlusive disease. Eur J Vasc Endovasc Surg2002;24:264-8.
  • 62. Basso F, Lowe GD, Rumley A et al. Interleukin-6-174 G>C polymorphism and risk of coronary heats disease in West of Scotland coronary prevention study. Arterio- scler Throm Vasc Biol2002;22:599-604.
  • 63. Pola R, Gaetani E, Flex A et al. -174 G/C interleukin- 6 gene polymorphism and increased risk of multi-infarct dementia: a case-control study. Exp Gerontol2002; 37:949-55.
  • 64. Macones G, Parry S, Elkousy M et al. A polymorphism in the promoter region of TNF and bacterial vaginosis: Preliminary evidence of gene-enviroment interaction in the ethiology of spontaneous preterm birth. Am J Ob- stet Gynecol2004;190:1504-8.
  • 65. Speer E, Gentile D, Zeevi A et al. Role of single polymorpfisms of cytokine genes in spontaneous preterm delivery. Human immunology2006;67:915-23.
  • 66. Cox ED, Hoffman SC, DiMercurio BS et al. Cytokine polymorphic analyses indicate ethnic differences in the allelic distribution of interleukin-2 and interleukin- 6. Transplantation2001;72:720-6.
  • 67. Reiman M, Kujari H, Ekholm E et al. Interleukin-6 polymorphism in associated with chorioamonionitis and neonatal infections in preterm infants. The Journal of Pediatrics2008;7:19-24.
  • 68. Annels MF, Hart PH, Mullighan CG et al. Interleukins-1, -4, -6, -10, tumor necrosis factor, transforming growth factor-B, FAS, and mannose-binding protein C gene polymorphisms in Australian women: Risk of pre- term birth. Am J Obstet Gynecol2004;191:2056-67.
  • 69. Fortunato S, Menon R, Velez D et al. Racial disparity in maternal-fetal genetic epistasis in spontaneous preterm birth. Am J Obstet Gynecol2008;198:666.e1-10.
  • 70. Menon R, Velez D, Thorsen P et al. Ethnic differences in key candidate genes for spontaneous preterm birth: TNF-A and its receptors. Hum Hered2006;62:107-18.
  • 71. Menon R, Merialdi M, Betran A et al. Analysis of association between maternal tumor necrosis factor-A promoter polymorphism (-308), tumor necrosis factor concentration, and preterm birth. Am J Obstet Gynecol2006;195:1240-8.
  • 72. Wilson AG, Symons JA, McDowell TL et al. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Na- tal Acad Sci USA1997;94:3195-9.
  • 73. McGuire W, Hill AV, Allsoff CE et al. Variation in the TNF A promoter region associated with susceptibility to cerebral malaria. Nature1994;371:508-11.
  • 74. Cabrera M, Shaw MA, Sharples C et al. Polymor- phism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med1995; 182: 1259-64.
  • 75. Roberts A, Monzon-Bordonaba F, Van Deerlin P et al. Association of polymorphism within the promoter of the tumor necrosis factor A gene with increased risk of preterm premature rupture of the fetal membranes. Am J Obstet Gynecol1999;5:1297-302.
  • 76. Menon R, Velez D, Morgan N et al. Genetic regulation of amniotic fluid TNF-alpha and soluble TNF receptor concentration affected by race and preterm birth. Hum Genet2008;124:243-53.
  • 77. Menon R, Thorsen P, Vogel I et al. Racial disparity in amniotic fluid concentrations of tumor necrosis factor (TNF)-A and soluble TNF receptors in spontaneous preterm birth. Am J Obstet Gynecol2008;198:533.e1- 10.
  • 78. Macones G, ParryS, MarderS et al. Evidence of a gene-enviroment interaction in the ethiology spontaneous preterm birth. Am J Obstet Gynecol2000;184:S3.
  • 79. Amory J, Adams K, Lin M et al. Adverse outcomes after preterm labour are associated with tumor necrosis factor-A polymorphism -863, but not -308, in mother- infant pairs. Am J Obstet Gynecol2004;191:1362-7.
  • 80. Aidoo M, McElroy PD, Kolczak MS et al. Tumor necrosis factor-alpha promoter variant 2 (TNF2) is as- sociated with pre-term delivery, infant mortality, and malaria morbidity in western Kenya: Asembo Bay Co- hort Project IX. Genet Epidemiol2001;21(3):201-11.
  • 81. Menon R, Velez D, Simhan H et al. Multilocus inte- ractions at maternal tumor necrosis factor-A, tumor necrosis factor receptors, interleukin-6 and interleukin- 6 receptor genes predict spontaneous preterm labor in European-American women. Am J Obstet Gynecol2006;194:1616-24.
  • 82. Moura E, Mattar R, de Souza E et al. Inflammatory cytokine gene polymorphisms and spontaneous preterm birth. Journal of Reproductive Immunology2009; 80:115–21.
  • 83. Kalinka J, Bitner A.Ocena związku polimorfizmu genów kodujących wybrane cytokiny z wystąpowaniem porodu przedwczesnego w populacji kobiet polskich. Ginekol Pol 2009; 80(2): 111-7.
  • 84. Kalinka J, Bitner A.Interleukin-1$ and interleukin-1 receptor antagonist genes polimorphisms and the risk of spontaneous preterm delivery in the population of Po- lish women. Archives of Perinatal Medicine2008; 14(4):33-6.
  • 85. Bitner A, Sobala W, Kalinka J. Association between maternal and fetal TLR4 (896A>G, 1196C>T) gene polymorphisms and the risk of pre-term birth in the polish population. American Journal of Reproductive Immuno- logy 2013;69:272-80.
  • 86. Bitner A, Kalinka J.IL-1ß, IL-6 promoter, TNF-α promoter and IL-1RA gene polymorphisms and the risk of preterm delivery due to preterm premature rupture of membranes in a population of Polish women. Arch Med Sci2010;6(4):552-7.
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.